NCT00459615View on ClinicalTrials.gov

Phase II Dose Ranging Study of Artesunate

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

January 31, 2008

Conditions
Falciparum MalariaUncomplicated Malaria
Interventions
DRUG

Artesunate for Injection

Trial Locations (2)

Unknown

New Nyanza Provincial Hospital, Kisumu

Kwai River Christian Hospital, Sangkhla Buri

All Listed Sponsors
collaborator

Military Infectious Diseases Research Program (MIDRP)

NETWORK

collaborator

U.S. Army Medical Research and Development Command

FED

lead

U.S. Army Office of the Surgeon General

FED

NCT00459615 - Phase II Dose Ranging Study of Artesunate | Biotech Hunter | Biotech Hunter